Antibody Drug Target Atlas In Oncology - Where To Commercialize In A Crowded Market Place?
Topics: Antibody Technologies, Hematology & Oncology, Oncology/Hematology
|
Patent map and technology intelligence report. Peptides
Topics: Antibody Technologies, Drug Discovery
|
Analytical Tool - Apoptosis in Oncology
Topics: Antibody Technologies, Oncology/Hematology
|
Immunotherapy in Oncology: Drug Pipeline Update 2010
Topics: Antibody Technologies, Vaccines, Oncology/Hematology
|
Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies
Topics: Antibody Technologies, Oncology/Hematology
|
Antibodies in Oncology: Drug Pipeline Update 2010
Topics: Antibody Technologies, Oncology/Hematology
|
Apoptosis in Oncology: Drug Pipeline Update 2010
Topics: Antibody Technologies, Oncology/Hematology
|
Chinese Markets for Monoclonal Antibody
Topics: Antibody Technologies
Regions: China
|
Stakeholder Opinions: Therapeutic Vaccines - A far-off promise of greatness
Topics: Antibody Technologies, Vaccines, Cancer Vaccines
|
Competitor Analysis Neurotrophic Growth Factors
Topics: Tissue Engineering, Antibody Technologies
|
The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Topics: Antibody Technologies
|
Apoptotic Therapeutics in Oncology - Where to Commercialize?
Topics: Antibody Technologies, Drug Discovery, Oncology/Hematology
|
Infectious Disease Testing Technologies: Market Applications of Current and Emerging Technologies
Topics: Antibody Technologies, In Vitro Diagnostics, Computed Tomography (CT), NMR & MRI, Infectious Diseases
|
Monoclonal antibodies: 2009 update
Topics: Research & Development, Antibody Technologies
|
Competitor Analysis: CXCR and CXCL Agonists and Antagonists
Topics: Antibody Technologies, Drug Discovery
|
Monoclonal Antibody Based Products - Global Trends
Topics: Antibody Technologies
Regions: Global
|
Freedonia Focus on Biologicals
Topics: Antibody Technologies, Vaccines, Biopharmaceuticals
Regions: United States
|
Regenerative Medicines: Bone and Joint Applications
Topics: General Biotechnology, Tissue Engineering, Biomaterials, Antibody Technologies, Orthopedics, Orthopedics
|
Forecast Insight: Top 20 Cancer Therapy Brands Targeted therapies will drive market growth in the wake of the cytotoxic and antihormonal patent cliff
Topics: Antibody Technologies, Pharmaceuticals Company Reports, Prescription Drugs, Oncology/Hematology
|
Expanding Applications of Personalized Medicine: Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach
Topics: Genomics, Antibody Technologies, Biomarkers
|
Bioarrays for Life Science Research, Diagnostics and Drug R&D
Topics: General Biotechnology, Genomics, Informatics, Antibody Technologies, In Vitro Diagnostics, Molecular Assays, Research & Development
|
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
Topics: Research & Development, Antibody Technologies
|
The 2010-2015 World Outlook for Monoclonal Antibody (MAb)-Based Products
Topics: Antibody Technologies
|
The 2010-2015 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
Topics: Antibody Technologies
|
Competitor Analysis: Immunotoxins
Topics: Proteomics, Antibody Technologies
|
Targeted Drug Delivery Technologies: Players, products & prospects to 2018 (Volume IV)
Topics: General Biotechnology, Emerging Technology, Antibody Technologies, Drug Delivery
|
Monoclonal Antibody Therapeutics 2009-2024
Topics: Antibody Technologies
|
Competitor Analysis: Antibody-Drug Conjugates (ADC)
Topics: Antibody Technologies
|
Competitor Analysis: Immunocytokines
Topics: Antibody Technologies
|
Therapeutic Monoclonal Antibodies Markets
Topics: Antibody Technologies
|
Monoclonal Antibodies in Cancer Therapy 2009-2024
Topics: Antibody Technologies, Oncology/Hematology
|
The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
Topics: Emerging Technology, Antibody Technologies, Biopharmaceuticals, Oncology/Hematology
Regions: Global
|
The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III
Topics: Antibody Technologies
|
Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines for Cancer
Topics: Antibody Technologies, Immunoassays, Vaccines, Oncology/Hematology
|
Competitor Analysis: CEA Antibodies
Topics: Antibody Technologies, Vaccines, Biopharmaceuticals
|
Competitor Analysis: EpCAM Antagonists
Topics: Antibody Technologies
|
Antibody Report: Market Overview and Industry Survey - Basic
Topics: Antibody Technologies
|
Antibody Report: Market Overview and Industry Survey - Premium
Topics: Antibody Technologies
|
Competitor Analysis: CD30 Antibodies
Topics: Antibody Technologies, Biopharmaceuticals
|
Competitor Analysis: CD22 Antibodies
Topics: Antibody Technologies, Biopharmaceuticals
|
Competitor Analysis: CD20 Antibodies
Topics: Antibody Technologies, Biopharmaceuticals
|
Delivering New Biopharmaceutical Therapies: Challenges & Opportunities
Topics: Antibody Technologies, Biopharmaceuticals
|
Therapeutic Clinical Intelligence - Rheumatoid Arthritis
Topics: Antibody Technologies, Arthritis, Biopharmaceuticals
|
Protein Therapeutics: Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments, Global Market
Topics: Proteomics, Antibody Technologies, Vaccines
|
RNA therapy: the next big thing after monoclonal antibodies?
Topics: Genomics, Antibody Technologies
|
Protein Drugs: Global Markets and Manufacturing Technologies
Topics: Proteomics, Antibody Technologies, Drug Discovery
Regions: Global
|
Monoclonal Antibody Based Products
Topics: Antibody Technologies
Regions: Global
|
European Therapeutic Monoclonal Antibody Markets
Topics: Antibody Technologies
Regions: Europe
|
Therapeutic Monoclonal Antibodies Report 2008-2023
Topics: Antibody Technologies
Regions: Global
|
Commercial Insight: Targeted Therapy Cancer Brands - High growth market will see eight new blockbusters by 2017
Topics: Antibody Technologies, Pharmaceuticals, Oncology/Hematology
|
